Uae Medical Affairs Outsourcing Market Size & Outlook
The medical affairs outsourcing market in the UAE is expected to reach a projected revenue of US$ 71.0 million by 2030. A compound annual growth rate of 13.3% is expected of the UAE medical affairs outsourcing market from 2023 to 2030.
The UAE medical affairs outsourcing market generated a revenue of USD 27.0 million in 2022 and is expected to reach USD 71.0 million by 2030.
The UAE market is expected to grow at a CAGR of 13.3% from 2023 to 2030.
In terms of segment, medical writing & publishing was the largest revenue generating services in 2022.
Medical Science Liaisons (MSLs) is the most lucrative services segment registering the fastest growth during the forecast period.
Medical affairs outsourcing market data book summary
Market revenue in 2022
USD 27.0 million
Market revenue in 2030
USD 71.0 million
Growth rate
13.3% (CAGR from 2023 to 2030)
Largest segment
Medical writing & publishing
Fastest growing segment
Medical Science Liaisons (MSLs)
Historical data
2018 - 2021
Base year
2022
Forecast period
2023 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Medical Writing & Publishing, Medical Monitoring, Medical Science Liaisons (MSLs), Medical Information
Key market players worldwide
IQVIA Holdings Inc, Icon PLC, The Medical Affairs Company, Syneos Health, Thermo Fisher Scientific Inc, Wuxi AppTec Co Ltd, SGS AG, Ashfield Healthcare, ZEINCRO Group, Indegene
Other key industry trends
In terms of revenue, UAE accounted for 1.6% of the global medical affairs outsourcing market in 2022.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa medical affairs outsourcing market is projected to lead the regional market in terms of revenue in 2030.
UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 71.0 million by 2030.
Currently, UAE is the third largest market for regulatory affairs outsourcing in the MEA region since most market players are dependent on imports. Medical device regulations in the country are based on Australian TGA, EU, and the U.S. regulations. Products with approval from the Canadian, Australian, EU, and the U.S. regulatory agencies are eligible for a short registration process in the UAE.
The UAE Government is focused on attracting innovative drug manufacturers by 2021, with double the number of local companies producing patented drugs. The country has a short drug registration system for both innovator and generic drugs approved by the U.S. FDA. Some of the examples of fast-tracked drugs in UAE are AbbVie’s Viekirax, Exviera (dasabuvir), and Eli Lilly's Trulicity.
Leading multinationals in the country include Sanofi, Novartis, Amgen, Pfizer, and GSK. Increase in the number of local and foreign players manufacturing innovator drugs will indirectly boost demand for medical affair services.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Medical Affairs Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Medical Writing & Publishing was the largest segment with a revenue share of 40.37% in 2022.
Horizon Databook has segmented the Uae medical affairs outsourcing market based on medical writing & publishing, medical monitoring, medical science liaisons (msls), medical information covering the revenue growth of each sub-segment from 2018 to 2030.
Currently, UAE is the third largest market for regulatory affairs outsourcing in the MEA region since most market players are dependent on imports. Medical device regulations in the country are based on Australian TGA, EU, and the U.S. regulations. Products with approval from the Canadian, Australian, EU, and the U.S. regulatory agencies are eligible for a short registration process in the UAE.
The UAE Government is focused on attracting innovative drug manufacturers by 2021, with double the number of local companies producing patented drugs. The country has a short drug registration system for both innovator and generic drugs approved by the U.S. FDA. Some of the examples of fast-tracked drugs in UAE are AbbVie’s Viekirax, Exviera (dasabuvir), and Eli Lilly's Trulicity.
Leading multinationals in the country include Sanofi, Novartis, Amgen, Pfizer, and GSK. Increase in the number of local and foreign players manufacturing innovator drugs will indirectly boost demand for medical affair services.
Uae Medical Affairs Outsourcing Market Services Outlook (Revenue, USD Million , 2018-2030)
Medical Writing & Publishing
Medical Monitoring
Medical Science Liaisons (MSLs)
Medical Information
Others
Uae Medical Affairs Outsourcing Market Industry Outlook (Revenue, USD Million , 2018-2030)
Pharmaceutical
Biopharmaceutical
Medical Devices
Reasons to subscribe to Medical Affairs Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Medical Affairs Outsourcing Market Outlook databook
Our clientele includes a mix of Medical Affairs Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Medical Affairs Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Medical Affairs Outsourcing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Uae Medical Affairs Outsourcing Market, 2018-2030 (US$M)